Erythromycin/sulfafurazole
| Combination of | |
|---|---|
| Erythromycin | Macrolide antibiotic |
| Sulfafurazole | Sulfonamide antibiotic |
| Clinical data | |
| Trade names | Pediazole |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
Erythromycin/sulfafurazole (trade name Pediazole) is a combination drug with the antibiotics erythromycin and sulfafurazole (the latter is also known as sulfisoxazole).
It is indicated in acute otitis media in children, particularly when Hemophilus influenzae is the suspected pathogen.[1]
References
- ^ erythromycin base/sulfisoxazole at Medscape. Retrieved April 29, 2013. Patient handout: [1].